REGIONAL SPECIFICS OF CARDIOVASCULAR MORBIDITY AND MORTALITY
نویسندگان
چکیده
منابع مشابه
Cardiovascular morbidity and mortality after kidney transplantation.
Kidney transplantation is the optimal treatment for patients with end stage renal disease (ESRD) who would otherwise require dialysis. Patients with ESRD are at dramatically increased cardiovascular (CV) risk compared with the general population. As well as improving quality of life, successful transplantation accords major benefits by reducing CV risk in these patients. Worldwide, cardiovascul...
متن کاملCardiovascular morbidity and mortality in COPD.
STUDY OBJECTIVE COPD and cardiovascular disease (CVD) share common risk factors. We undertook to estimate rates of hospitalization and death from CVD in COPD patients relative to the general population. DESIGN AND SETTING A cohort of patients > or = 55 years old receiving a first treatment for COPD between 1990 and 1997 was formed from the Saskatchewan Health databases. All hospitalizations a...
متن کاملElectrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality
The Wolf–Parkinson–White (WPW) syndrome is a clinical entity characterized by the presence of ≥1 accessory pathways between the atria and the ventricles pre-disposing patients to arrhythmias. Anterograde conduction through the accessory pathway leads to preexcitation of the ventricles and a delta wave in the ECG. The prevalence of preexcitation in the general population has been estimated to be...
متن کاملChronic kidney disease as cause of cardiovascular morbidity and mortality.
To make an evidence-based evaluation of the relationship between kidney failure and cardiovascular risk, we reviewed the literature obtained from a PubMed search using pre-defined keywords related to both conditions and covering 18 years (1986 until end 2003). Eighty-five publications, covering 552 258 subjects, are summarized. All but three studies support a link between kidney dysfunction and...
متن کاملChronic renal disease and risk of cardiovascular morbidity-mortality.
The pathogenesis of cardiovascular disease in CKD differs subtly from that of non-CKD patients. As renal function declines, the role and impact of treating classical risk factors may change and diminish. However, hypertension, hypercholesterolaemia and smoking cessation management should be optimized and may require multiple agents and approaches, particularly as CKD advances. Hypertension trea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiovascular Therapy and Prevention
سال: 2016
ISSN: 2619-0125,1728-8800
DOI: 10.15829/1728-8800-2016-4-66-69